University of Melbourne and Colossal expand partnership with gift to support avian conservation
Posted: 10 December 2024 A US$1.5 million gift from the Colossal Foundation, a non-profit organisation established by Colossal Biosciences, will help researchers in the Faculty of Science develop new approaches to the conservation of bird species in Australia and…
Breakthrough Victoria invests in game changing aged care technology
Posted: 10 December 2024 Breakthrough Victoria is investing $2 million in Umps Health, a Victorian company developing sensors and AI to enable proactive aged care at home. The Umps Link, a smart home platform, is the product of…
Australian researchers win the ‘Nobel’ of high-performance computing
Posted: 10 December 2024 An Australian research team and their American collaborators have been awarded the 2024 Gordon Bell Prize, regarded as the ‘Nobel Prize’ of high-performance computing (HPC). University of Melbourne Associate Professor Giuseppe Barca and his team were named the winners…
University of Melbourne and Peter MacCallum Cancer Centre leading genomics-driven cancer prevention
Posted: 10 December 2024 Genomics-driven cancer prevention, testing and treatment strategies will be at the forefront of a new joint venture between the University of Melbourne and Peter MacCallum Cancer Centre (Peter Mac), announced in Melbourne today. The…
High blood pressure and shorter sleep may worsen brain decline: study
Posted: 10 December 2024 People with high blood pressure who also lack sleep may be at increased risk of reduced cognitive performance and greater brain injury, Monash University research has found. Published in the Journal of the American Heart…
World Leading Moderna Vaccine Facility Opens In Victoria
Posted: 10 December 2024 The Southern Hemisphere’s only mRNA manufacturing facility has opened in Victoria – backed by the Albanese and Allan Labor Governments – ensuring world-class mRNA vaccines and medicines can be made in Australia and creating…
Discovery Project applications awarded more than $342 million
Posted: 10 December 2024 The Australian Research Council (ARC) today announced more than $342 million in funding for 536 new projects under the 2025 ARC Discovery Projects scheme. ARC Acting Chief Executive Officer, Dr Richard Johnson, said the…
Cynata secures commitments for $8.1m via an institutional placement following positive Diabetic Foot Ulcer Phase 1 clinical trial results
Posted: 10 December 2024 Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has received firm commitments for a placement of 44,444,445 new,…
AGRF Partners with Integrated Sciences to Offer Cutting-Edge Epigenetic Services with EpiCypher CUT&RUN and CUT&Tag Technologies
Posted: 5 December 2024 AGRF (Australian Genome Research Facility Ltd) and Integrated Sciences are excited to announce a new partnership that will bring advanced genomics capabilities to researchers across Australia and New Zealand. This collaboration will enable AGRF’s…
INOVIQ completes disease specificity testing for breast cancer
Posted: 5 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce the successful completion of disease specificity testing for breast cancer. The INOVIQ blood test is a simple, accurate and affordable immunoassay developed using a monoclonal…
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
Posted: 4 December 2024 Telix and Grand Pharma today announce that a first patient has been dosed in the Phase III ZIRCON-CP trial of TLX250-CDx positron emission tomography (PET) imaging of clear cell renal cell carcinoma (ccRCC). The…
Ovarian Cancer Test Delivers Outstanding Diagnostic Performance
Posted: 4 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that its blood test for ovarian cancer screening has successfully completed an independent patient validation of its biomarkers and diagnostic performance, delivering outstanding test results…
